Phase 3b WAYFINDER data show tezepelumab oral corticosteroid reduction in severe asthma, with nearly 90 percent reaching 5 mg ...
Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The ...
HealthDay News — For adults with oral corticosteroid (OCS)-dependent severe uncontrolled asthma, tezepelumab can help to reduce OCS use, according to a study published online November 26 in The Lancet ...
Over half of patients with severe asthma discontinued oral corticosteroids while maintaining disease control, major study ...
R-CHOP plus ibrutinib, followed by ibrutinib maintenance improved PFS in treatment-naive patients aged 65 years and younger with high-risk ABC DLBCL.
Everyday Health on MSN
Does Crohn’s Disease Raise Your Risk of Kidney Stones?
Find out about the link between Crohn’s disease and kidney stones, and get actionable tips from experts on diet and medication to minimize your risk.
UK: A new study published in The Lancet Respiratory Medicine reports that tezepelumab can significantly reduce the need for oral corticosteroids (OCS) in adults with severe, uncontrolled asthma who ...
Patients with severe hypertriglyceridemia treated with olezarsen vs. placebo had a significantly greater decline in ...
The IDEXX Cancer Dx is a new blood-based screening/diagnostic panel aimed at detecting canine lymphoma from serum or whole ...
Feelings of glee and wonder not unlike walking into an arcade full of classic games befell me as I booted up Atari 50: The Anniversary Celebration, gawking at its wide and varied wonders. This ...
The U.S. Food and Drug Administration has approved Pfizer's Padcev (enfortumab vedotin-ejfv), a Nectin-4 directed ...
Citi Annual Global Healthcare Conference 2025 December 2, 2025 1:00 PM ESTCompany ParticipantsRichard John Daly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback